- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Amyotrophic lateral sclerosis (ALS)
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 554KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 100KB)
Edaravone – March 2024
Edaravone: Solution concentrate for injection I.V. infusion 30 mg in 20 mL; Radicava®
Last updated
30 May 2025